These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 35062215)

  • 21. Mild and Severe SARS-CoV-2 Infection Induces Respiratory and Intestinal Microbiome Changes in the K18-hACE2 Transgenic Mouse Model.
    Seibert B; Cáceres CJ; Cardenas-Garcia S; Carnaccini S; Geiger G; Rajao DS; Ottesen E; Perez DR
    Microbiol Spectr; 2021 Sep; 9(1):e0053621. PubMed ID: 34378965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. K18-hACE2 mice develop respiratory disease resembling severe COVID-19.
    Yinda CK; Port JR; Bushmaker T; Offei Owusu I; Purushotham JN; Avanzato VA; Fischer RJ; Schulz JE; Holbrook MG; Hebner MJ; Rosenke R; Thomas T; Marzi A; Best SM; de Wit E; Shaia C; van Doremalen N; Munster VJ
    PLoS Pathog; 2021 Jan; 17(1):e1009195. PubMed ID: 33465158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19.
    Clark JJ; Penrice-Randal R; Sharma P; Dong X; Pennington SH; Marriott AE; Colombo S; Davidson A; Kavanagh Williamson M; Matthews DA; Turtle L; Prince T; Hughes GL; Patterson EI; Shawli G; Mega DF; Subramaniam K; Sharp J; Turner JD; Biagini GA; Owen A; Kipar A; Hiscox JA; Stewart JP
    Viruses; 2024 May; 16(6):. PubMed ID: 38932155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhalable nanocatchers for SARS-CoV-2 inhibition.
    Zhang H; Zhu W; Jin Q; Pan F; Zhu J; Liu Y; Chen L; Shen J; Yang Y; Chen Q; Liu Z
    Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34292870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Animal Models of COVID-19: Transgenic Mouse Model.
    Park JG; Pino PA; Akhter A; Alvarez X; Torrelles JB; Martinez-Sobrido L
    Methods Mol Biol; 2022; 2452():259-289. PubMed ID: 35554912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice.
    Zeng J; Xie X; Feng XL; Xu L; Han JB; Yu D; Zou QC; Liu Q; Li X; Ma G; Li MH; Yao YG
    EBioMedicine; 2022 Jan; 75():103803. PubMed ID: 34979342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research.
    Dedoni S; Avdoshina V; Camoglio C; Siddi C; Fratta W; Scherma M; Fadda P
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.
    Kim SH; Kim J; Jang JY; Noh H; Park J; Jeong H; Jeon D; Uhm C; Oh H; Cho K; Jeon Y; On D; Yoon S; Lim SY; Kim SP; Lee YW; Jang HJ; Park IH; Oh J; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Kim SY; Kim YB; Hwang JY; Lee HJ; Kim HB; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Kim K; Lee D; Lee H; Nam KT; Seong JK
    Front Immunol; 2022; 13():1055811. PubMed ID: 36457995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development.
    Zhang Z; Zhou L; Liu Q; Zheng Y; Tan X; Huang Z; Guo M; Wang X; Chen X; Liang S; Li W; Song K; Yan K; Li J; Li Q; Zhang Y; Yang S; Cai Z; Dai M; Xian Q; Shi ZL; Xu K; Lan K; Chen Y
    Emerg Microbes Infect; 2024 Dec; 13(1):2353302. PubMed ID: 38753462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling.
    Israelow B; Song E; Mao T; Lu P; Meir A; Liu F; Alfajaro MM; Wei J; Dong H; Homer RJ; Ring A; Wilen CB; Iwasaki A
    J Exp Med; 2020 Dec; 217(12):. PubMed ID: 32750141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.
    Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW
    mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of transgenic models susceptible and resistant to SARS-CoV-2 infection in FVB background mice.
    Seo SM; Son JH; Lee JH; Kim NW; Yoo ES; Kang AR; Jang JY; On DI; Noh HA; Yun JW; Park JW; Choi KS; Lee HY; Shin JS; Seo JY; Nam KT; Lee H; Seong JK; Choi YK
    PLoS One; 2022; 17(7):e0272019. PubMed ID: 35881617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of a humanized mAce2 and a conditional hACE2 mouse models permissive to SARS-COV-2 infection.
    Song IW; Washington M; Leynes C; Hsu J; Rayavara K; Bae Y; Haelterman N; Chen Y; Jiang MM; Drelich A; Tat V; Lanza DG; Lorenzo I; Heaney JD; Tseng CK; Lee B; Marom R
    Mamm Genome; 2024 Jun; 35(2):113-121. PubMed ID: 38488938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice.
    Paull JRA; Luscombe CA; Castellarnau A; Heery GP; Bobardt MD; Gallay PA
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of neutrophil chemoattractant CXCL5 in SARS-CoV-2 infection-induced lung inflammatory innate immune response in an
    Liang Y; Li H; Li J; Yang ZN; Li JL; Zheng HW; Chen YL; Shi HJ; Guo L; Liu LD
    Zool Res; 2020 Nov; 41(6):621-631. PubMed ID: 33045777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium.
    Sims AC; Burkett SE; Yount B; Pickles RJ
    Virus Res; 2008 Apr; 133(1):33-44. PubMed ID: 17451829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Generation of SARS-CoV-2 Mouse Model by Transient Expression of the Human ACE2 Gene Mediated by Intranasal Administration of AAV-hACE2].
    Glazkova DV; Bogoslovskaya EV; Urusov FA; Kartashova NP; Glubokova EA; Gracheva AV; Faizuloev EB; Trunova GV; Khokhlova VA; Bezborodova OA; Pankratov AA; Leneva IA; Shipulin GA
    Mol Biol (Mosk); 2022; 56(5):774-782. PubMed ID: 36165016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. H1N1 exposure during the convalescent stage of SARS-CoV-2 infection results in enhanced lung pathologic damage in hACE2 transgenic mice.
    Li H; Zhao X; Zhao Y; Li J; Zheng H; Xue M; Guo L; Zhou J; Yang J; Zuo Y; Chen Y; Yang Z; Fan Q; Qin L; Shi H; Liu L
    Emerg Microbes Infect; 2021 Dec; 10(1):1156-1168. PubMed ID: 34060982
    [No Abstract]   [Full Text] [Related]  

  • 39. Age associated susceptibility to SARS-CoV-2 infection in the K18-hACE2 transgenic mouse model.
    Dwivedi V; Shivanna V; Gautam S; Delgado J; Hicks A; Argonza M; Meredith R; Turner J; Martinez-Sobrido L; Torrelles JB; Kulkarni V
    Geroscience; 2024 Jun; 46(3):2901-2913. PubMed ID: 38388916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains.
    Radvak P; Kwon HJ; Kosikova M; Ortega-Rodriguez U; Xiang R; Phue JN; Shen RF; Rozzelle J; Kapoor N; Rabara T; Fairman J; Xie H
    Nat Commun; 2021 Nov; 12(1):6559. PubMed ID: 34772941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.